BNP Paribas Asset Management’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.92M Sell
18,724
-11,713
-38% -$5.41M 0.01% 740
2026
Q1
$14.6M Buy
30,437
+5,486
+22% +$2.81M 0.02% 605
2025
Q4
$14M Buy
24,951
+24,707
+10,126% +$14M 0.02% 608
2025
Q3
$125K Sell
244
-4
-2% -$1.75K ﹤0.01% 819
2025
Q2
$78K Buy
+248
New +$74.5K ﹤0.01% 993

Other funds holding MEDP

BNP Paribas Asset Management's MEDP Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Medpace (MEDP) stake by 38% in Q2 2026, selling an estimated $5.41M and leaving 18,724 shares worth $9.92M. The position accounts for 0.01% of the portfolio, ranked #740.

BNP Paribas Asset Management first reported a position in MEDP in Q2 2025 and has held it in 5 quarters since. The position peaked at $14.6M in Q1 2026. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • BNP Paribas Asset Management held 18,724 shares of Medpace worth $9.92M as of Q2 2026.
  • BNP Paribas Asset Management sold 11,713 Medpace shares in Q2 2026, an estimated $5.41M.
  • Medpace made up 0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #740 holding.
  • BNP Paribas Asset Management first reported a position in Medpace in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Medpace position peaked at $14.6M in Q1 2026.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.